Stock of the Week – Fulcrum Therapeutics (FULC)
Our Stock of the Week is Fulcrum Therapeutics (FULC). Fulcrum Therapeutics is a biopharmaceutical company that focuses on developing small molecules to treat rare diseases with unmet medical needs. The company has two main programs in clinical development. The first...Stock of the Week – TG Therapeutics (TGTX)
TG Therapeutics (TGTX) is a commercial-stage biopharmaceutical firm that treats autoimmune diseases, cancers, and other B-cell diseases. The company has received approval from the FDA for Briumvi, which treats patients with relapsing forms of multiple sclerosis. The...Stock of the Week – Viking Therapeutics (VKTX)
Our Stock of the Week is Viking Therapeutics (VKTX). Viking is racing to launch an obesity drug that competes against Lilly (LLY) and Novo Nordisk (NVO). Preliminary results for its VK2735 showed excellent results with substantial weight reduction and fewer side...Stock of the Week – Lantheus Holdings, Inc. (LNTH)
Our Stock of the Week is Lantheus Holdings, Inc. (LNTH). LNTH is a radiopharmaceutical company that develops, manufactures, and sells diagnostic and therapeutic products for nuclear medicine and diagnostic imaging. Their products help healthcare professionals with...
Sponsored by
